No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A multi-center cohort study

Breast Cancer Research and Treatment

Volumn 115, Issue 1, 2009, Pages 185-192

  Rebbeck, Timothy R ^a   Antoniou, Antonis C ^b   Llopis, Trinidad Caldes ^c   Nevanlinna, Heli ^d   Aittomäki, Kristiina ^d   Simard, Jacques ^e   Spurdle, Amanda B ^f   Couch, Fergus J ^g   Pereira, Lutecia H Mateus ^h,i   Greene, Mark H ^h   Andrulis, Irene L ^j,k   Pasche, Boris ^l,m   Kaklamani, Virginia ^l,m   Hamann, Ute ⁿ   Szabo, Csilla ^g   Peock, Susan ^b   Cook, Margaret ^b   Harrington, Patricia A ^b   Donaldson, Alan ^o   Male, Allison M ^p   Gardiner, Carol Anne ^q   Gregory, Helen ^r   Side, Lucy E ^s   Robinson, Anne C ^t   Emmerson, Louise ^u   Ellis, Ian ^v   Peyrat, Jean Philippe ^w   Fournier, Joëlle ^w   Vennin, Philippe ^w   Adenis, Claude ^w   Muller, Danièle ^x   Fricker, Jean Pierre ^x   Longy, Michel ^y   Sinilnikova, Olga M ^z   Stoppa Lyonnet, Dominique ^aa   Schmutzler, Rita K ^ab   Versmold, Beatrix ^ab   Engel, Christoph ^ac   Meindl, Alfons ^ad   Kast, Karin ^ae   Schaefer, Dieter ^af   Froster, Ursula G ^ac   Chenevix Trench, Georgia ^f   Easton, Douglas F ^b   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITÉ LAVAL   (Canada)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g MAYO CLINIC   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF MIAMI   (United States)

^j MOUNT SINAI HOSPITAL   (Canada)

^k CANCER CARE ONTARIO   (Canada)

^l NORTHWESTERN UNIVERSITY   (United States)

^m Cancer Care Ontario   (Canada)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o ST MICHAEL'S HOSPITAL   (United Kingdom)

^p GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^q NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^r UNIVERSITY OF ABERDEEN   (United Kingdom)

^s CHURCHILL HOSPITAL   (United Kingdom)

^t BASILDON HOSPITAL   (United Kingdom)

^u GLAN CLWYD HOSPITAL   (United Kingdom)

^v ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^w CENTRE OSCAR LAMBRET   (France)

^x CENTRE PAUL STRAUSS   (France)

^y INSTITUT BERGONIÉ   (France)

^z UNIVERSITÉ LYON 1   (France)

^aa INSTITUT CURIE   (France)

^ab UNIVERSITY OF COLOGNE   (Germany)

^ac UNIVERSITY OF LEIPZIG   (Germany)

^ad TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ae DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^af GOETHE UNIVERSITY   (Germany)

more..

Author keywords

BRCA1; BRCA2; Hereditary cancer; Risk modifiers

Indexed keywords

BRCA2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENOTYPE; HAZARD RATIO; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; POPULATION; PRIORITY JOURNAL;

EID: 67349158309     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0064-8     Document Type: Article

References (28)

1. B Bierie HL Moses 2006 Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer Nat Rev Cancer 6 7 506 520 10.1038/nrc1926
2. R Derynck RJ Akhurst A Balmain 2001 TGF-beta signaling in tumor suppression and cancer progression Nat Genet 29 2 117 129 10.1038/ng1001-117
3. E Ziv J Cauley PA Morin R Saiz WS Browner 2001 Association between the T29→C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: the study of osteoporotic fractures JAMA 285 22 2859 2863 10.1001/jama.285.22.2859
4. M Yokota S Ichihara TL Lin N Nakashima Y Yamada 2000 Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese Circulation 101 24 2783 2787
5. AM Dunning PD Ellis S McBride HL Kirschenlohr CS Healey PR Kemp 2003 A transforming growth factor beta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer Cancer Res 63 10 2610 2615
6. VG Kaklamani L Baddi J Liu D Rosman S Phukan C Bradley 2005 Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk Cancer Res 65 8 3454 3461
7. Q Jin K Hemminki E Grzybowska R Klaes M Soderberg H Zientek 2004 Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers Int J Cancer 112 1 94 99 10.1002/ijc.20370
8. P Krippl U Langsenlehner W Renner B Yazdani-Biuki G Wolf TC Wascher 2003 The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk Cancer Lett 201 2 181 184 10.1016/S0304-3835(03) 00468-3
9. L Le Marchand CA Haiman D van den Berg LR Wilkens LN Kolonel BE Henderson 2004 T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the multiethnic cohort study Cancer Epidemiol Biomarkers Prev 13 3 412 415
10. KM Lee SK Park N Hamajima K Tajima KY Yoo A Shin 2005 Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk Breast Cancer Res Treat 90 2 149 155 10.1007/s10549-004-3859-2
11. A Shin XO Shu Q Cai YT Gao W Zheng 2005 Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages Cancer Epidemiol Biomarkers Prev 14 6 1567 1570 10.1158/1055-9965.EPI-05-0078
12. A Hishida H Iwata N Hamajima K Matsuo M Mizutani T Iwase 2003 Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women Breast Cancer 10 1 63 69
13. Breast Cancer Association C 2006 Commonly studied single-nucleotide polymorphisms and breast cancer: results from the breast cancer association consortium J Natl Cancer Inst 98 19 1382 1396
14. AM Gonzalez-Zuloeta Ladd A Arias-Vasquez C Siemes JW Coebergh A Hofman J Witteman 2007 Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity Eur J Cancer 43 2 371 374 10.1016/j.ejca.2006.08.021
15. XO Shu YT Gao Q Cai L Pierce H Cai ZX Ruan 2004 Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai breast cancer study Cancer Res 64 3 836 839 10.1158/0008-5472.CAN-03-3492
16. A Cox AM Dunning M Garcia-Closas S Balasubramanian MW Reed KA Pooley 2007 A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 3 352 358 10.1038/ng1981
17. D Cox K Penney Q Guo S Hankinson D Hunter 2007 TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the nurses' health study BMC Cancer 7 175 10.1186/1471-2407-7-175
18. G Chenevix-Trench RL Milne AC Antoniou FJ Couch DF Easton DE Goldgar 2007 An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) Breast Cancer Res 9 2 104 10.1186/bcr1670
19. A Antoniou PD Pharoah S Narod HA Risch JE Eyfjord JL Hopper 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 1130 10.1086/375033
20. Antoniou A, Sinilnikova O, Simard J, Léoné M, Dumont M, Neuhausen S, Struewing JLD, Barjhoux L, Hughes D, Coupier I et al (2007) RAD51 135G>C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81:1186-1200
21. AC Antoniou DE Goldgar N Andrieu J Chang-Claude R Brohet MA Rookus 2005 A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes Genet Epidemiol 29 1 1 11 10.1002/gepi.20074
22. DY Lin LJ Wei 1989 The robust inference for the Cox proportional hazards model JASA 84 1074 1078
23. PJ Huber 1967 The behavior of maximum likelihood estimates under non-standard conditions Proc Fifth Berkley Symp Math Stat Probab 1 221 233
24. K Lange D Weeks M Boehnke 1988 Programs for pedigree analysis: MENDEL, FISHER, and dGENE Genet Epidemiol 5 471 472 10.1002/gepi.1370050611
25. HT Zhang J Zhao SY Zheng XF Chen 2005 Is TGFBR1*6A really associated with increased risk of cancer? J Clin Oncol 23 30 7743 7744 10.1200/JCO.2005.02.9108 author reply 7744-7746
26. SR Lakhani MJ Van De Vijver J Jacquemier TJ Anderson PP Osin L McGuffog 2002 The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 9 2310 2318 10.1200/JCO.2002.09.023
27. AL Bane JC Beck I Bleiweiss SS Buys E Catalano MB Daly 2007 BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays Am J Surg Pathol 31 1 121 128 10.1097/01.pas.0000213351.49767.0f
28. A Cox AM Dunning M Garcia-Closas S Balasubramanian MW Reed KA Pooley 2007 Corrigendum: a common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 5 688 10.1038/ng0507-688b